BioSpace News Archive

Propanc Biopharma Peer Reviewed Scientific Article Reaches 3,000 Reads

Propanc Biopharma, Inc. announced that a peer reviewed scientific article published by the Company and its research partners reached 3,000 reads on July 6, 2023, according to ResearchGate.

July 13, 2023
·
6 min read
FDA

Perrigo Announces U.S. FDA Approval for Opill® OTC Daily Oral Contraceptive

Perrigo Company plc announced today that the U.S. Food and Drug Administration (FDA) approved Opill ® , a progestin-only daily oral contraceptive, for over-the-counter (OTC) use for all ages.

July 13, 2023
·
4 min read
Biotech Bay

Aerin Medical Announces New Positive Two-Year Results from VivAer® AERWAY Study

Aerin Medical Inc. today announced the publication of positive two-year follow-up data from the AERWAY trial for patients with severe or extreme nasal airway obstruction (NAO) due to nasal valve collapse (NVC).

July 13, 2023
·
6 min read
NIH Awards $3.6 million to Fund Rosalind Franklin University Research on Rejection Sensitivity in Sexual Minority Adolescents

Rosalind Franklin University (RFU) psychologist Brian Feinstein, PhD, is determined to improve the health of one of the nation’s most vulnerable populations — sexual minority youth

July 13, 2023
·
2 min read
Drug Development

Skye Bioscience Receives Positive Safety Review for Final Cohort of Fully-Enrolled Phase 1 Study of SBI-100 Ophthalmic Emulsion

Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye” or the “Company”), a pharmaceutical company developing a proprietary, synthetic cannabinoid derivative to treat glaucoma

July 13, 2023
·
3 min read
Business

Dr. Preetinder Bhullar, Board-Certified Orthopedic Surgeon and Decorated Air Force Major, Joins Mendelson Kornblum Orthopedics Spine and Pain Specialists

Dr. Preetinder Bhullar, MD, is a board-certified and fellowship-trained orthopedic surgeon. His expertise is in hip and knee replacements, specifically direct anterior hip replacement.

July 13, 2023
·
2 min read
Biotech Beach

Emmaus Life Sciences Receives Marketing Authorization for Endari® in Oman

Emmaus Life Sciences, Inc., a leader in sickle cell disease treatment, announced that it has received marketing authorization from the Oman Ministry of Health for the commercial distribution and sale of Endari® in the country to treat sickle cell disease in patients five years of age and older.

July 13, 2023
·
4 min read
Drug Development

Incannex Receives HREC Approval for Phase 2 Clinical Trial Assessing IHL-675A for use in Treatment of Pain and Function in Rheumatoid Arthritis

Incannex Healthcare Limited is pleased to announce that it has received approval from Bellberry Human Research Ethics Committee (‘HREC’) for the lead site, Emeritus Research, Camberwell, Victoria, for its Phase 2 clinical trial.

July 13, 2023
·
10 min read
Drug Development

Grifols Meets Enrollment Target in Phase 3 Study of Two Dose Regimens of Prolastin®-C in Patients with Emphysema Due to Alpha-1-Antitrypsin Deficiency

Grifols (MCE: GRF, MCE: GRF.P NASDAQ: GRFS), one of the world’s leading producers of plasma-derived medicines, today announced it has met its enrollment target of 339 patients in SPARTA (Study of ProlAstin-c Randomized Therapy with Alpha-1 augmentation.

July 13, 2023
·
8 min read
Deals

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - July 13, 2023

Scholar Rock today announced that the company granted inducement equity awards covering an aggregate of 72,625 shares of its common stock to 6 newly hired employees.

July 13, 2023
·
3 min read